Physician profile
Albert Ayoub
NPI 1043309834
$3,757.47
in general payments reported to CMS, 2019-2025
23 companies · $370 in 2025
The $370 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.45 · 2021: $221 · 2022: $1,085 · 2023: $1,334 · 2024: $719 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,423.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $592.31 | 2022-2024 | |
| Myriad Women'S Health, INC. | $518.42 | 2023 | Myrisk |
| Daiichi Sankyo INC. | $371.58 | 2019-2023 | Injectafer |
| Aspira Women'S Health INC | $265.76 | 2022 | |
| Biogen, INC. | $235.57 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $210.13 | 2023-2025 | Veozah, Myrbetriq |
| Agile Therapeutics, INC. | $183.39 | 2022-2023 | Twirla |
| Sumitomo Pharma America, INC. | $177.06 | 2023-2025 | Myfembree |
| Alydia Health | $154.91 | 2021 | |
| Evofem Biosciences, INC. | $148.13 | 2022-2025 | Phexxi, Solosec, Phexx |
| Abbvie INC. | $135.04 | 2022-2025 | Lo Loestrin Fe, Orilissa |
| Scynexis, INC. | $114.59 | 2022 | |
| Organon LLC | $100.58 | 2022-2025 | Nexplanon |
| Pfizer INC. | $90.29 | 2021-2024 | |
| Shield Therapeutics INC | $83.67 | 2023-2024 | Accrufer |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $75.38 | 2022 | |
| Coopersurgical, INC. | $70.55 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $67.09 | 2024-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $47.70 | 2024-2025 | |
| Therapeuticsmd, INC. | $40.20 | 2021-2022 | |
| Hologic Sales and Service, LLC | $40.07 | 2025 | Aptima |
| Avion Pharmaceuticals | $20.41 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $14.64 | 2023 | Vivjoa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Ayoub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.